{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001807983","name":"Medicenna Therapeutics Corp.","summary":"Medicenna Therapeutics Corp. is a clinical-stage biopharmaceutical company focused on developing immunotherapies for cancer. Its pipeline includes MDNA11, a beta-only IL-2 superkine being evaluated in the Phase 1/2 ABILITY Study, and BiSKIT candidates. The company also has IL-4 and IL-13 based Empowered Cytokine programs, including work on recurrent glioblastoma (rGBM). Medicenna has no approved products or product revenue and relies on external funding for research and development.","people":[],"products":[{"name":"MDNA11","type":"platform","description":"Beta-only IL-2 superkine immunotherapy candidate being evaluated in the Phase 1/2 ABILITY Study for cancer treatment."},{"name":"BiSKIT","type":"platform","description":"Bispecific immunotherapy candidate platform with a lead candidate advancing toward IND enabling studies."},{"name":"Empowered Cytokines (IL-4/IL-13 based)","type":"platform","description":"IL-4 and IL-13 receptor-targeting cytokine fusion protein candidates, including programs for recurrent glioblastoma."}],"partnerships":[{"partner_name":"Leland Stanford Junior University (Stanford)","partnership_type":"licensing","description":"Stanford is referenced as a named partner/licensor in the company's glossary and technology relationships.","start_date":null},{"partner_name":"Cancer Prevention and Research Institute of Texas (CPRIT)","partnership_type":"strategic","description":"CPRIT is referenced in the company's glossary, indicating a funding or research relationship.","start_date":null}],"affiliations":[],"origin":{"leaf":"de7f9d1a449c772229946773071cbafbbd6b5c5be036a80d2bc515eaa9eab5d7","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"8ac92e5fd5311b443976f56e561485e0a4b588e20da3d2e000c3f4b9111c9054","parent":"ceb177ff7feaa52007d60c65202b205f6292d69a6bb6e46a1850f412eeb1d0e0","source":"0001171843-23-004170","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":500,"hourly_limit":500,"remaining":0,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}